Invasive Circuitry-Based Neurotherapeutics: Stereotactic Ablation and Deep Brain Stimulation for OCD

Psychiatric neurosurgery, specifically stereotactic ablation, has continued since the 1940s, mainly at a few centers in Europe and the US. Since the late 1990s, the resurgence of interest in this field has been remarkable; reports of both lesion procedures and the newer technique of deep brain stimulation (DBS) have increased rapidly. In early 2009, the US FDA granted limited humanitarian approval for DBS for otherwise intractable obsessive-compulsive disorder (OCD), the first such approval for a psychiatric illness. Several factors explain the emergence of DBS and continued small-scale use of refined lesion procedures. DBS and stereotactic ablation have been successful and widely used for movement disorders. There remains an unmet clinical need: current drug and behavioral treatments offer limited benefit to some seriously ill people. Understandings of the neurocircuitry underlying psychopathology and the response to treatment, while still works in progress, are much enhanced. Here, we review modern lesion procedures and DBS for OCD in the context of neurocircuitry. A key issue is that clinical benefit can be obtained after surgeries targeting different brain structures. This fits well with anatomical models, in which circuits connecting orbitofrontal cortex (OFC), medial prefrontal cortex (mPFC), basal ganglia, and thalamus are central to OCD pathophysiology and treatment response. As in movement disorders, dedicated interdisciplinary teams, here led by psychiatrists, are required to implement these procedures and maintain care for patients so treated. Available data, although limited, support the promise of stereotactic ablation or DBS in carefully selected patients. Benefit in such cases appears not to be confined to obsessions and compulsions, but includes changes in affective state. Caution is imperative, and key issues in long-term management of psychiatric neurosurgery patients deserve focused attention. DBS and contemporary ablation also present different patterns of potential benefits and burdens. Translational research to elucidate how targeting specific nodes in putative OCD circuitry might lead to therapeutic gains is accelerating in tandem with clinical use.

[1]  W. J. German Psychosurgery. Intelligence, Emotion and Social Behavior Following Prefrontal Lobotomy for Mental Disorders , 1942, The Yale Journal of Biology and Medicine.

[2]  W. Freeman,et al.  Psychosurgery: Intelligence, emotion, and social behavior following prefrontal lobotomy for mental disorders. , 1942 .

[3]  J. Pool,et al.  PSYCHOSURGERY IN OLDER PEOPLE , 1954, Journal of the American Geriatrics Society.

[4]  T. Powell,et al.  The cortico-striate projection in the monkey. , 1970, Brain : a journal of neurology.

[5]  A. Richardson,et al.  Stereotactic Limbic Leucotomy: A Preliminary Report on Forty Patients , 1973, British Journal of Psychiatry.

[6]  G. Knight Further observations from an experience of 660 cases of stereotactic tractotomy , 1973, Postgraduate medical journal.

[7]  U. Malm,et al.  A controlled long‐term study of flunitrazepam, nitrazepam and placebo, with special regard to withdrawal effects , 1978, Acta psychiatrica Scandinavica.

[8]  Harold I. Kaplan,et al.  Comprehensive textbook of psychiatry/III , 1980 .

[9]  D. Pandya,et al.  Some observations on the course and composition of the cingulum bundle in the rhesus monkey , 1984, The Journal of comparative neurology.

[10]  E. Valenstein Great and Desperate Cures: The Rise and Decline of Psychosurgery and Other Radical Treatments for Mental Illness , 1987, Psychological Medicine.

[11]  T. Greitz,et al.  Regional cerebral glucose metabolism in anxiety disorders studied with positron emission tomography before and after psychosurgical intervention. A preliminary report. , 1986, Acta radiologica. Supplementum.

[12]  K. Bergström,et al.  Magnetic resonance imaging of stereotactic radiosurgical lesions in the internal capsule. , 1986, Acta radiologica. Supplementum.

[13]  H. Ballantine,et al.  Treatment of psychiatric illness by stereotactic cingulotomy , 1987, Biological Psychiatry.

[14]  D. Pandya,et al.  Cingulate cortex of the rhesus monkey: II. Cortical afferents , 1987, The Journal of comparative neurology.

[15]  T. Insel,et al.  Clomipramine in obsessive-compulsive disorder. Further evidence for a serotonergic mechanism of action. , 1989, Archives of general psychiatry.

[16]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[17]  J. Deveaugh-Geiss,et al.  Clomipramine in obsessive-compulsive disorder , 1990, Biological Psychiatry.

[18]  S. Lee Clomipramine in obsessive compulsive disorder. , 1991, The Journal of clinical psychiatry.

[19]  R. Goldstein,et al.  A family study of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[20]  P Pietrini,et al.  Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Revisualization during pharmacotherapy. , 1992, Archives of general psychiatry.

[21]  R. Hales,et al.  J Neuropsychiatry Clin Neurosci , 1992 .

[22]  T. Nordahl,et al.  Preliminary data on the metabolic brain pattern of patients with winter seasonal affective disorder. , 1992, Archives of general psychiatry.

[23]  J. Mazziotta,et al.  Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[24]  S. Rasmussen,et al.  The epidemiology and clinical features of obsessive compulsive disorder. , 1992, The Psychiatric clinics of North America.

[25]  Richard S. J. Frackowiak,et al.  The metabolic effects of limbic leucotomy in Gilles de la Tourette syndrome. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[26]  S. Cumming,et al.  Treatment of obsessive‐compulsive disorder by psychosurgery , 1993, Acta psychiatrica Scandinavica.

[27]  L. Baer Factor analysis of symptom subtypes of obsessive compulsive disorder and their relation to personality and tic disorders. , 1994, The Journal of clinical psychiatry.

[28]  P K Bridges,et al.  Psychosurgery: Stereotactic Subcaudate Tractotomy , 1994, British Journal of Psychiatry.

[29]  J. Leysen,et al.  Risperidone: a novel antipsychotic with balanced serotonin-dopamine antagonism, receptor occupancy profile, and pharmacologic activity. , 1994, The Journal of clinical psychiatry.

[30]  C D Frith,et al.  Functional Anatomy of Obsessive–Compulsive Phenomena , 1994, British Journal of Psychiatry.

[31]  N. Alpert,et al.  Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. , 1994, Archives of general psychiatry.

[32]  C Lindquist,et al.  Neurosurgical treatment for refractory obsessive-compulsive disorder: implications for understanding frontal lobe function. , 1994, The Journal of neuropsychiatry and clinical neurosciences.

[33]  S. Rasmussen,et al.  The epidemiology and differential diagnosis of obsessive compulsive disorder. , 1992, The Journal of clinical psychiatry.

[34]  Suck-Won Kim,et al.  The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency , 1994, Psychiatry Research.

[35]  M Ashtari,et al.  Reduced caudate nucleus volume in obsessive-compulsive disorder. , 1995, Archives of general psychiatry.

[36]  P. Blier,et al.  Alteration of Serotonin Release in the Guinea Pig Orbito-Frontal Cortex by Selective Serotonin Reuptake Inhibitors , 1995, Neuropsychopharmacology.

[37]  V S Caviness,et al.  Cerebral structural abnormalities in obsessive-compulsive disorder. A quantitative morphometric magnetic resonance imaging study. , 1996, Archives of general psychiatry.

[38]  Streichenwein Sm,et al.  Am J Psychiatry , 1996 .

[39]  D. Zald,et al.  Anatomy and function of the orbital frontal cortex, I: anatomy, neurocircuitry; and obsessive-compulsive disorder. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[40]  M E Phelps,et al.  Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[41]  Alan D. Lopez,et al.  Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study , 1997, The Lancet.

[42]  N. Alpert,et al.  Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. , 1997, The Journal of neuropsychiatry and clinical neurosciences.

[43]  D. Murphy,et al.  The role of neurotransmitters and neurohormones in obsessive± compulsive disorder , 1997 .

[44]  O. Speck,et al.  1H-magnetic resonance spectroscopy in obsessive-compulsive disorder: evidence for neuronal loss in the cingulate gyrus and the right striatum , 1997, Psychiatry Research: Neuroimaging.

[45]  Michael E Phelps,et al.  FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder , 1998, Psychiatry Research: Neuroimaging.

[46]  K. Kobak,et al.  Behavioral versus pharmacological treatments of obsessive compulsive disorder: a meta-analysis , 1998, Psychopharmacology.

[47]  R W Neufeld,et al.  A short echo 1H spectroscopy and volumetric MRI study of the corpus striatum in patients with obsessive-compulsive disorder and comparison subjects. , 1998, The American journal of psychiatry.

[48]  N. Alpert,et al.  Neural Correlates of Factor-Analyzed OCD Symptom Dimensions: A PET Study , 1998, CNS Spectrums.

[49]  D. Murphy,et al.  Delayed obsessive-compulsive disorder symptom exacerbation after a single dose of a serotonin antagonist in fluoxetine-treated but not untreated patients , 1998, Psychopharmacology.

[50]  G. Curtis,et al.  Treatment of Tourette’s Syndrome With Delta-9-Tetrahydrocannabinol , 1999 .

[51]  Neurosurgery for obsessive-compulsive disorder: problems with comorbidity. , 1999, The American journal of psychiatry.

[52]  S. Alborzian,et al.  Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder , 1999, Neuropsychopharmacology.

[53]  J. Gybels,et al.  Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder , 1999, The Lancet.

[54]  L. Koran Obsessive-Compulsive and Related Disorders in Adults: A Comprehensive Clinical Guide , 1999 .

[55]  B. Lippitz,et al.  Lesion topography and outcome after thermocapsulotomy or gamma knife capsulotomy for obsessive-compulsive disorder: relevance of the right hemisphere. , 1999, Neurosurgery.

[56]  E. Brown Last resort: psychosurgery and the limits of medicine , 1999, Medical History.

[57]  E. Bullmore,et al.  A differential neural response in obsessive–compulsive disorder patients with washing compared with checking symptoms to disgust , 2000, Psychological Medicine.

[58]  M. Keshavan,et al.  Decrease in caudate glutamatergic concentrations in pediatric obsessive-compulsive disorder patients taking paroxetine. , 2000, Journal of the American Academy of Child and Adolescent Psychiatry.

[59]  B. Erwin,et al.  Mechanisms of deep brain stimulation and future technical developments , 2000, Neurological research.

[60]  D. Binder,et al.  Modern neurosurgery for psychiatric disorders. , 2000, Neurosurgery.

[61]  P. Costa,et al.  Personality disorders and normal personality dimensions in obsessive-compulsive disorder , 2000, British Journal of Psychiatry.

[62]  Surgery for psychiatric disorders. , 2000 .

[63]  B H Price,et al.  Volume reduction in the caudate nucleus following stereotactic placement of lesions in the anterior cingulate cortex in humans: a morphometric magnetic resonance imaging study. , 2000, Journal of neurosurgery.

[64]  G. Cosgrove Surgery for Psychiatric Disorders , 2000, CNS Spectrums.

[65]  S. Rauch,et al.  Improvement in severe self-mutilation following limbic leucotomy: a series of 5 consecutive cases. , 2001, The Journal of clinical psychiatry.

[66]  R. Hoehn-Saric,et al.  The relationship between obsessive–compulsive disorder and anxiety and affective disorders: results from the Johns Hopkins OCD Family Study , 2001, Psychological Medicine.

[67]  D. Chambless,et al.  Effects of axis I and II comorbidity on behavior therapy outcome for obsessive-compulsive disorder and agoraphobia. , 2001, Comprehensive psychiatry.

[68]  S. Rauch,et al.  A Magnetic Resonance Imaging Study of Regional Cortical Volumes Following Stereotactic Anterior Cingulotomy , 2001, CNS Spectrums.

[69]  H. Zhang,et al.  Symptom dimensions in obsessive-compulsive disorder: toward quantitative phenotypes. , 2001, American journal of medical genetics.

[70]  Darin D Dougherty,et al.  Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder , 2001, Biological Psychiatry.

[71]  S. Salloway,et al.  The frontal lobes and neuropsychiatric illness , 2001 .

[72]  R. P. Feldman,et al.  Contemporary psychosurgery and a look to the future. , 2001, Journal of neurosurgery.

[73]  Nikolaus R. McFarland,et al.  Thalamic Relay Nuclei of the Basal Ganglia Form Both Reciprocal and Nonreciprocal Cortical Connections, Linking Multiple Frontal Cortical Areas , 2002, The Journal of Neuroscience.

[74]  M. Kao A new mode of percutaneous upper thoracic phenol sympathicolysis: report of 50 cases. , 2002, Neurosurgery.

[75]  M. Kim,et al.  Review of long-term results of stereotactic psychosurgery. , 2002, Neurologia medico-chirurgica.

[76]  S. Rauch,et al.  Prospective long-term follow-up of 44 patients who received cingulotomy for treatment-refractory obsessive-compulsive disorder. , 2002, The American journal of psychiatry.

[77]  J. Vitek Mechanisms of deep brain stimulation: Excitation or inhibition , 2002, Movement disorders : official journal of the Movement Disorder Society.

[78]  C. Gonsalvez,et al.  Response inhibition deficits in obsessive–compulsive disorder , 2002, Psychiatry Research.

[79]  Chan-Hyung Kim,et al.  Anterior cingulotomy for refractory obsessive–compulsive disorder , 2003, Acta psychiatrica Scandinavica.

[80]  J. Fins From psychosurgery to neuromodulation and palliation: history's lessons for the ethical conduct and regulation of neuropsychiatric research. , 2003, Neurosurgery clinics of North America.

[81]  J. Gybels,et al.  Long-term Electrical Capsular Stimulation in Patients with Obsessive-Compulsive Disorder , 2003, Neurosurgery.

[82]  J. Gybels,et al.  Deep brain stimulation for treatment‐refractory obsessive‐compulsive disorder: psychopathological and neuropsychological outcome in three cases , 2003, Acta psychiatrica Scandinavica.

[83]  A. Addington,et al.  The identification of OCD-related subgroups based on comorbidity , 2003, Biological Psychiatry.

[84]  J. Gybels,et al.  Effects of electrical stimulation or lesion in nucleus accumbens on the behaviour of rats in a T-maze after administration of 8-OH-DPAT or vehicle , 2003, Behavioural Brain Research.

[85]  S. Rauch Neuroimaging and neurocircuitry models pertaining to the neurosurgical treatment of psychiatric disorders. , 2003, Neurosurgery clinics of North America.

[86]  B. Greenberg,et al.  Serotonin transporter missense mutation associated with a complex neuropsychiatric phenotype , 2003, Molecular Psychiatry.

[87]  S. Rauch,et al.  Neurosurgery for intractable obsessive-compulsive disorder and depression: critical issues. , 2003, Neurosurgery clinics of North America.

[88]  H. Westenberg,et al.  A score for predicting response to pharmacotherapy in obsessive–compulsive disorder , 2003, International clinical psychopharmacology.

[89]  Weiss,et al.  Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for treatment of major depression. , 2003, Journal of neurosurgery.

[90]  H. Westenberg,et al.  Effect of a pharmacological intervention on quality of life in patients with obsessive–compulsive disorder , 2003, International clinical psychopharmacology.

[91]  H. Westenberg,et al.  The role of dopamine in obsessive-compulsive disorder: preclinical and clinical evidence. , 2004, The Journal of clinical psychiatry.

[92]  Colette Fabrigoule,et al.  Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive-compulsive disorder and major depression. Case report. , 2004, Journal of neurosurgery.

[93]  L. Summerfeldt Understanding and treating incompleteness in obsessive-compulsive disorder. , 2004, Journal of clinical psychology.

[94]  M. Phillips,et al.  Distinct neural correlates of washing, checking, and hoarding symptom dimensions in obsessive-compulsive disorder. , 2004, Archives of general psychiatry.

[95]  Kamryn T. Eddy,et al.  A multidimensional meta-analysis of psychotherapy and pharmacotherapy for obsessive-compulsive disorder. , 2004, Clinical psychology review.

[96]  Benjamin D. Greenberg,et al.  What's in a “Smile?” Intra-operative Observations of Contralateral Smiles Induced by Deep Brain Stimulation , 2004, Neurocase.

[97]  N. V. D. Van der Wee,et al.  Enhanced dopamine transporter density in psychotropic-naive patients with obsessive-compulsive disorder shown by [123I]{beta}-CIT SPECT. , 2004, The American journal of psychiatry.

[98]  S. Rauch,et al.  Pharmacotherapy for obsessive-compulsive disorder. , 2004, Journal of clinical psychology.

[99]  P. Cannistraro,et al.  Clinical correlates of recurrent major depression in obsessive–compulsive disorder , 2004, Depression and anxiety.

[100]  B. Aouizerate,et al.  Deep brain stimulation of the ventral caudate nucleus in the treatment of obsessive—compulsive disorder and major depression , 2004 .

[101]  N. Swindale,et al.  Diffusion tensor fiber tracking shows distinct corticostriatal circuits in humans , 2004, Annals of neurology.

[102]  E. Katz,et al.  Cerebral glucose metabolism in obsessive-compulsive hoarding. , 2004, The American journal of psychiatry.

[103]  N. Shapira,et al.  A Review of the Treatment for Refractory Obsessive-Compulsive Disorder: From Medicine to Deep Brain Stimulation , 2004, CNS Spectrums.

[104]  S. E. Stewart,et al.  Effectiveness of intensive residential treatment (IRT) for severe, refractory obsessive-compulsive disorder. , 2005, Journal of psychiatric research.

[105]  J. Sheehan,et al.  Late cyst formation following gamma knife surgery of arteriovenous malformations. , 2005, Journal of neurosurgery.

[106]  J. El-Hai The Lobotomist: A Maverick Medical Genius and His Tragic Quest to Rid the World of Mental Illness , 2005 .

[107]  T. Robbins,et al.  The neuropsychology of obsessive compulsive disorder: the importance of failures in cognitive and behavioural inhibition as candidate endophenotypic markers , 2005, Neuroscience & Biobehavioral Reviews.

[108]  Manzar Ashtari,et al.  White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. , 2005, Archives of general psychiatry.

[109]  N. Kathmann,et al.  Implicit Sequence Learning in Obsessive-Compulsive Disorder: Further Support for the Fronto-Striatal Dysfunction Model , 2005, Biological Psychiatry.

[110]  M. Kozak,et al.  Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. , 2007, The American journal of psychiatry.

[111]  S. Taylor,et al.  Deep brain stimulation for refractory obsessive-compulsive disorder , 2005, Biological Psychiatry.

[112]  R. Persaud The Lobotomist: A Maverick Medical Genius and his Tragic Quest to Rid the World of Mental Illness , 2005, BMJ : British Medical Journal.

[113]  D. Denys,et al.  Predictors of pharmacotherapy response in anxiety disorders , 2005, Current psychiatry reports.

[114]  P. Blier,et al.  Responsiveness of 5-HT(1A) and 5-HT2 receptors in the rat orbitofrontal cortex after long-term serotonin reuptake inhibition. , 2005, Journal of psychiatry & neuroscience : JPN.

[115]  R. Heimberg,et al.  Not just right experiences and obsessive-compulsive features: experimental and self-monitoring perspectives. , 2005, Behaviour research and therapy.

[116]  S. Haber,et al.  Reward-Related Cortical Inputs Define a Large Striatal Region in Primates That Interface with Associative Cortical Connections, Providing a Substrate for Incentive-Based Learning , 2006, The Journal of Neuroscience.

[117]  H. Westenberg,et al.  Association between the dopamine D2 receptor TaqI A2 allele and low activity COMT allele with obsessive–compulsive disorder in males , 2006, European Neuropsychopharmacology.

[118]  B. Greenberg,et al.  Education and neuromodulation for psychiatric disorders: a perspective for practitioners. , 2006, Neurosurgery.

[119]  Frameless stereotactic subcaudate tractotomy for intractable obsessive–compulsive disorder , 2006, Acta Neurochirurgica.

[120]  B. Greenberg,et al.  The brown longitudinal obsessive compulsive study: treatments received and patient impressions of improvement. , 2006, The Journal of clinical psychiatry.

[121]  Patrick Dupont,et al.  Metabolic imaging of anterior capsular stimulation in refractory obsessive-compulsive disorder: a key role for the subgenual anterior cingulate and ventral striatum. , 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[122]  N. Alpert,et al.  A functional neuroimaging investigation of deep brain stimulation in patients with obsessive-compulsive disorder. , 2006, Journal of neurosurgery.

[123]  S. Rasmussen,et al.  The Brown Longitudinal Obsessive Compulsive Study: clinical features and symptoms of the sample at intake. , 2006, The Journal of clinical psychiatry.

[124]  G. Friehs,et al.  Three-Year Outcomes in Deep Brain Stimulation for Highly Resistant Obsessive–Compulsive Disorder , 2006, Neuropsychopharmacology.

[125]  David Goldman,et al.  Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. , 2006, American journal of human genetics.

[126]  B. Greenberg,et al.  Psychosurgery: avoiding an ethical redux while advancing a therapeutic future. , 2006, Neurosurgery.

[127]  P. Lang,et al.  Panic and fear induced by deep brain stimulation , 2005, Journal of Neurology, Neurosurgery & Psychiatry.

[128]  Anthony Pinto,et al.  Impact of obsessive-compulsive disorder on quality of life. , 2006, Comprehensive psychiatry.

[129]  P. Blier,et al.  Pharmacotherapies in the Management of Obsessive—Compulsive Disorder , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[130]  Nikos Makris,et al.  A diffusion tensor imaging study of white matter in obsessive–compulsive disorder , 2007, Depression and anxiety.

[131]  A. Grace,et al.  High-Frequency Deep Brain Stimulation of the Nucleus Accumbens Region Suppresses Neuronal Activity and Selectively Modulates Afferent Drive in Rat Orbitofrontal Cortex In Vivo , 2007, The Journal of Neuroscience.

[132]  H. Westenberg,et al.  Neurobiology of Obsessive-Compulsive Disorder: Serotonin and Beyond , 2007, CNS Spectrums.

[133]  Warren M. Grill,et al.  Antidromic propagation of action potentials in branched axons: implications for the mechanisms of action of deep brain stimulation , 2008, Journal of Computational Neuroscience.

[134]  T. Robbins,et al.  Impaired cognitive flexibility and motor inhibition in unaffected first-degree relatives of patients with obsessive-compulsive disorder. , 2007, The American journal of psychiatry.

[135]  A. Heinz,et al.  Reduced availability of serotonin transporters in obsessive-compulsive disorder correlates with symptom severity – a [11C]DASB PET study , 2007, Journal of Neural Transmission.

[136]  S. Rauch,et al.  Functional Magnetic Resonance Imaging Study of Regional Brain Activation During Implicit Sequence Learning in Obsessive–Compulsive Disorder , 2007, Biological Psychiatry.

[137]  D. Pandya,et al.  Efferent Association Pathways from the Rostral Prefrontal Cortex in the Macaque Monkey , 2007, The Journal of Neuroscience.

[138]  M. Riddle,et al.  Two times four is four: OCD dimensions, classes, and categories. , 2008, Journal of the American Academy of Child and Adolescent Psychiatry.

[139]  D. Murphy,et al.  A novel, putative gain-of-function haplotype at SLC6A4 associates with obsessive-compulsive disorder. , 2007, Human molecular genetics.

[140]  D. Cho,et al.  Limbic leukotomy for intractable major affective disorders: A 7-year follow-up study using nine comprehensive psychiatric test evaluations , 2008, Journal of Clinical Neuroscience.

[141]  D. Rizopoulos,et al.  Comparative study of the effects of electrical stimulation in the nucleus accumbens, the mediodorsal thalamic nucleus and the bed nucleus of the stria terminalis in rats with schedule-induced polydipsia , 2008, Brain Research.

[142]  J. Gybels,et al.  LONG‐TERM ELECTRICAL CAPSULAR STIMULATION IN PATIENTS WITH OBSESSIVE‐COMPULSIVE DISORDER , 2008, Neurosurgery.

[143]  David H. Zald,et al.  The Orbitofrontal Cortex , 2008 .

[144]  C. Pittenger,et al.  Meta-analysis of the symptom structure of obsessive-compulsive disorder. , 2008, The American journal of psychiatry.

[145]  B. Nuttin,et al.  Applicants for stereotactic neurosurgery for psychiatric disorders: role of the Flemish advisory board , 2008, Acta psychiatrica Scandinavica.

[146]  V. Willour,et al.  Further development of YBOCS dimensions in the OCD Collaborative Genetics Study: Symptoms vs. categories , 2008, Psychiatry Research.

[147]  B. Greenberg,et al.  Correlates of occupational disability in a clinical sample of obsessive-compulsive disorder. , 2008, Comprehensive psychiatry.

[148]  Hans-Jürgen Möller,et al.  World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Pharmacological Treatment of Anxiety, Obsessive-Compulsive and Post-Traumatic Stress Disorders – First Revision , 2002, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[149]  Li-Hong Shi,et al.  Studies of the neural mechanisms of deep brain stimulation in rodent models of Parkinson's disease , 2008, Neuroscience & Biobehavioral Reviews.

[150]  T. Robbins,et al.  Orbitofrontal Dysfunction in Patients with Obsessive-Compulsive Disorder and Their Unaffected Relatives , 2008, Science.

[151]  Alessandra Gorini,et al.  In vivo PET study of 5HT2A serotonin and D2 dopamine dysfunction in drug-naive obsessive-compulsive disorder , 2008, NeuroImage.

[152]  M. Keshavan,et al.  Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: A preliminary voxel-based morphometry study , 2008, Neuroscience Letters.

[153]  S. Rauch,et al.  Gamma ventral capsulotomy for treatment of resistant obsessive-compulsive disorder: A structural MRI pilot prospective study , 2008, Neuroscience Letters.

[154]  E. Miguel,et al.  Personality traits and treatment outcome in obsessive-compulsive disorder. , 2008, Revista brasileira de psiquiatria.

[155]  S. Rauch,et al.  Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. , 2008, The American journal of psychiatry.

[156]  Andreas Karlsson,et al.  Capsulotomy for obsessive-compulsive disorder: long-term follow-up of 25 patients. , 2008, Archives of general psychiatry.

[157]  Michael X. Cohen,et al.  Deep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression , 2008, Neuropsychopharmacology.

[158]  J. Grafman,et al.  A psychological and neuroanatomical model of obsessive-compulsive disorder. , 2008, The Journal of neuropsychiatry and clinical neurosciences.

[159]  P. Szeszko,et al.  Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. , 2008, The American journal of psychiatry.

[160]  Thomas R. Insel,et al.  Deep Brain Stimulation in Psychiatry: Concentrating on the Road Ahead , 2009, Biological Psychiatry.

[161]  A. Egerton,et al.  Dopamine Release in the Human Striatum: Motor and Cognitive Tasks Revisited , 2009, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[162]  Suzanne N Haber,et al.  Scientific and ethical issues related to deep brain stimulation for disorders of mood, behavior, and thought. , 2009, Archives of general psychiatry.

[163]  D. Rosenberg,et al.  Glutamate receptor gene (GRIN2B) associated with reduced anterior cingulate glutamatergic concentration in pediatric obsessive–compulsive disorder , 2009, Psychiatry Research: Neuroimaging.

[164]  A. Grace,et al.  Nucleus Accumbens Deep Brain Stimulation Produces Region-Specific Alterations in Local Field Potential Oscillations and Evoked Responses In Vivo , 2009, The Journal of Neuroscience.

[165]  D. Pandya,et al.  Delineation of the middle longitudinal fascicle in humans: a quantitative, in vivo, DT-MRI study. , 2009, Cerebral cortex.

[166]  Diane M. Beck,et al.  Top-down and bottom-up mechanisms in biasing competition in the human brain , 2009, Vision Research.

[167]  H. Groenewegen,et al.  The major symptom dimensions of obsessive-compulsive disorder are mediated by partially distinct neural systems. , 2008, Brain : a journal of neurology.

[168]  S. Rauch,et al.  Deep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression , 2009, Biological Psychiatry.

[169]  Shailendra Kapoor,et al.  Subthalamic nucleus stimulation in severe obsessive-compulsive disorder. , 2009, The New England journal of medicine.

[170]  A. Benabid,et al.  Deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease , 2009, The Lancet Neurology.

[171]  B. Greenberg,et al.  Treatment of resistant obsessive-compulsive disorder with ventral capsular/ventral striatal gamma capsulotomy: a pilot prospective study. , 2009, The Journal of neuropsychiatry and clinical neurosciences.

[172]  G. Friehs,et al.  Deep brain stimulation of the ventral internal capsule/ventral striatum for obsessive-compulsive disorder: worldwide experience , 2010, Molecular Psychiatry.

[173]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[174]  Paul E Holtzheimer,et al.  Deep brain stimulation for psychiatric disorders. , 2011, Annual review of neuroscience.